Background and Objectives: For patients with cutaneous melanoma, primary tumors located in the head and neck is associated with poor outcomes. The reason for this difference and whether it is applicable to all locations within the head and neck remains unclear. We hypothesized that scalp melanoma is uniquely distinguished from other anatomic sites and is independently responsible for the poor prognosis of head and neck melanoma.
Methods: Query and analysis of a prospectively maintained melanoma database of all patients treated for primary cutaneous melanoma from 1971 to 2010.
Results: Of 11 384 patients identified, 7% (n = 799) of lesions originated on the scalp.
Scalp primaries were more often found in males and were associated with increased Breslow thickness and were more frequently ulcerated compared to all other anatomic sites (P = 0.0001). On multivariate analysis, scalp location was an independent predictor of worse melanoma-specific (HR 1.75; CI 1.50-2.04; P < 0.0001) and overall survival (HR 1.62; CI 1.41-1.86; P < 0.0001).
Conclusions: This, the largest series examining scalp melanoma, confirms that scalp location is independently responsible for the negative prognosis associated with head and neck melanoma. Although the pathophysiology of this difference remains to be determined, these data argue for more rigorous surveillance of this anatomic location.
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| INTRODUCTION
Despite heightened public awareness and improvement in early detection through screening programs, cutaneous melanoma continues to represent one of several cancers with increasing incidence over the last several decades. 1 In particular, melanoma arising from the head and neck region as a subgroup is being diagnosed with increased frequency. 2 Primary cutaneous melanoma of the head and neck consists of lesions arising on the scalp, face, ears, and neck, each occurring with distinct individual frequencies. 3 As a group, head and neck melanoma has long been associated with a worse overall prognosis compared to cutaneous melanoma arising from all other anatomic sites. 4 Whether these differences in long term outcomes may be attributed to unique anatomic, biologic, or environmental factors remains unclear.
Melanoma arising on the scalp, as a subset of head and neck melanoma, has in the past been recognized as a "high-risk" anatomic location. [5] [6] [7] Large population based studies using the surveillance, epidemiology, and end results (SEER) database have suggested that scalp location may be an independent factor contributing to negative outcomes, in particular worse melanoma-specific and overall survival. 8, 9 Unfortunately, these studies have been constrained by the fact that scalp and neck melanoma are a combined category in the SEER database, so delineating the true impact of scalp location alone was not possible. In smaller series, examining the relative impact of individual sites of the head and neck generated conflicting results. 10, 11 Therefore, to our knowledge, the clinical implication of scalp location on head and neck melanoma has not been adequately defined. We hypothesized that the scalp is associated with an outcome profile that distinguishes it from all other anatomic sites and is responsible for the generally poor prognosis attributed to melanoma of the head and neck.
| METHODS
We queried our prospectively maintained database from 1971 through 2010 for all patients diagnosed with cutaneous melanoma and having a known primary site. In order to avoid referral bias favoring recurrent cases as well as the effect of treatment delay due to referral time, analysis was limited to patients who were treated at our institution compared between anatomic sites of the primary cutaneous melanoma using chi-square test. Melanoma-specific (MSS) and overall survival (OS) by primary site were analyzed and compared using Kaplan-Meier (7) 57 (5) 75 (9) 504 (8) 853 (7) N2 130 (4) 36 (3) 49 (6) 259 (4) 474 (4) N3 86 (3) 13 (1) 42 (5) 163 (3) 304 ( (23) 216 (17) 241 (30) 1490 (24) 2668 (23) IV 315 (10) 209 (17) 132 (17) 818 (13) 1474 ( method and compared using the log-rank test. In order to account for survival differences based on stage, stage for stage survival analysis was performed. In order to identify significant independent predictors of 5-year MSS and OS, multivariable analysis using Cox proportionalhazards model was performed using a step-wise selection procedure to select the factors included in the final model.
| RESULTS
A total of 11 384 patients with a known primary melanoma were treated at our institution between January 1, 1971 and December 31, 2010. Of those 7% (n = 799) originated on the scalp. The remainder of head and neck melanomas (face/neck/ear) consisted of 11% (n = 1241) of all melanomas treated at our center during the study period (Table 1) . Males made up the majority (58%) of cases of melanoma and male gender was more common among all anatomic sites except extremity melanoma, which was more common among females. The proportion of males presenting with scalp lesions were significantly greater than any other anatomic site (80%, P = 0.0001). Patients with trunk melanoma were significantly younger at the time of diagnosis compared to all other anatomic sites (P < 0.0001). On average, lesions of the scalp were thicker at presentation (2.6 mm) compared to melanomas on the remainder of the head and neck (1.7 mm) (P < 0.0001). In addition, presence of ulceration was less frequently identified in non-scalp head and neck locations compared to lesions of the scalp (10% vs 16%, P = 0.0001) ( Table 2) . Tumor-positive lymph nodes were more commonly associated with scalp primaries (20%) than any other anatomic site (P = 0.0001).
On univariate analysis, scalp location was associated with significantly reduced 5-year OS for all stages compared to all other anatomic sites (P < 0.0001) (Fig. 1A) . When stage IV patients were excluded from analysis a statistically significant worse overall survival remained (P < 0.0001) among scalp melanoma patients compared to the other groups (Fig. 1B) . This effect persisted when anatomic site was compared stage for stage among stage I and II patients ( (Table 3) . Other head and neck primary tumor locations were not significantly associated with outcomes worse than 
| DISCUSSION
The role of primary anatomic site as a prognostic indicator in cutaneous melanoma has been debated for decades. biopsy. This study reaffirmed that tumor site was indeed an independent predictor of mortality with scalp location being associated with the highest rate of recurrence and a more than three-fold greater mortality than tumors of the face. 13 In the Sunbelt Melanoma Trial, among patients who underwent sentinel lymph node biopsy for melanomas >1.0 mm in thickness and clinically negative nodal disease, scalp and non-scalp head, and neck melanoma had differing clinical and histopathological features that affected long term outcomes. Of their 109 scalp melanoma patients, sentinel lymph node status was the strongest predictor of overall survival while in non-scalp melanoma patients, Breslow thickness and presence of ulceration were the primary predictors associated with reduced survival. 14 Unfortunately, while each of these series is informative, conclusions drawn are Using the SEER database, scalp and neck melanoma were associated with significantly decreased MSS and OS compared with other areas of the head and neck. 8, 9 The most recent of these studies by Tseng et al featured a robust number of patients (n = 27 097) of which 34%
presented with melanoma of the scalp or neck. Unfortunately, SEER does not differentiate between scalp and neck melanoma, instead combining both of these anatomic sites into one category for analysis.
Therefore, it is impossible to assess the true impact of scalp location alone.
In the current study, we sought to compare a pure population of primary cutaneous scalp melanoma patients to all other anatomic sites at a single institution using a large prospectively maintained melanoma database. We found that non-scalp head and neck melanoma had similar 5-year MSS and OS compared to melanoma of the trunk and extremities. Conversely, scalp melanoma was associated with significantly worse 5-year MSS and OS. Even after excluding stage IV patients, scalp primary site, thicker Breslow, lymph node positivity, presence of ulceration, older age, and male gender were all found to be associated with significantly worse overall and melanoma-specific survival. Taken together these findings suggest that scalp melanoma represents a distinct entity and is probably responsible for the generally poor prognosis associated with head and neck melanoma. In addition, scalp melanoma appears to behave in a more aggressive fashion compared to melanoma originating from other anatomic sites.
Several theories have been proposed to explain why scalp melanoma may be associated with worse outcomes compared to melanoma originating from other anatomic sites. The lymphatic drainage pattern of the scalp is complex and can often be variable and unpredictable. [15] [16] [17] To highlight this fact, it has previously been reported that the rate of false-negative sentinel lymph node biopsy in head and neck melanoma may be as high as 32%. 18 Therefore, anatomic variations in lymphatic drainage patterns of the head and neck may predispose to greater risk of distant site recurrence. This was demonstrated in the current study, as scalp location was independently associated with worse distant disease-free survival compared to all other anatomic sites. In addition, it has been hypothesized that given anatomic constraints of the scalp, patients may undergo inadequate excision predisposing to higher rates of local recurrence. 19 Finally, as shown in this study, melanoma of the scalp typically presents at more advanced stages with thicker lesions, more frequently are ulcerated and more commonly are associated with nodal involvement. Taken together, these findings may suggest that scalp lesions go unrecognized due to their location or possibly are associated with longer delay times between time of patient recognition and initial presentation to a health care provider.
Recently, mutations in the N-ras oncogene have been recognized as a common genetic mutation occurring in cutaneous melanoma with an incidence as high as 18%. 20 This mutation has been associated with specific histologic subtypes of melanoma as well as distinctive tumor locations, predominately being found in nodular melanoma arising in the setting of areas of chronic sun-damaged skin secondary to exposure to ultraviolet radiation. 20, 21 Head and neck melanoma, given their anatomic location and propensity for sun exposure, appears to be particularly susceptible to N-ras mutations. Jiveskog et al compared frequencies of N-ras mutations between sun-exposed areas of the head and neck to unexposed regions of the body and found N-ras to be mutated in 32% of head and neck melanoma specimens, but only 7% of melanomas developing in unexposed sites. 22 N-ras mutations have also been shown to be associated with thicker lesions and have higher rates of mitotic activity. Furthermore, N-ras mutation appears to be an independent adverse prognostic factor associated with decreased MSS (HR 2.96, P = 0.04). 23 Therefore, a complex combination of anatomic, biologic, and environmental factors may be contributing to the aggressive nature and pathogenesis of scalp melanoma.
There are several limitations to the current study. 
| CONCLUSION
We report the largest series of scalp melanoma to date. Scalp melanoma is associated with reduced melanoma-specific and overall survival compared to non-scalp head and neck, trunk, and extremity melanoma. Thus, scalp melanoma alone may be responsible for the overall poor long term outcomes of head and neck melanoma as a whole. Additional studies are warranted to ascertain unique biologic, anatomic, or environmental factors contributing to the pathogenesis of scalp melanoma.
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